Share of Domestic Medicines in Kazakhstan Reaches 40.3%
Summary
Kazakhstani pharmaceutical enterprises boosted production to 191 billion tenge, bringing the domestic medicines market share to 40.3%.
Prepared by the newsroom with AI assistance; the original link is always provided
The market share of domestically manufactured medicines in Kazakhstan has reached 40.3%, reflecting the growing capacity of local producers.
Kazakhstani pharmaceutical companies increased their total production volume to 191 billion tenge. The rise in domestic output contributes to strengthening the country's pharmaceutical security and expanding local supply.
Source: inbusiness.kz
Read the original →Latest news
Bank CenterCredit Repurchases Shares for 18.2B Tenge on KASE
Bank CenterCredit JSC has repurchased 4.1 million of its common shares on the Kazakhstan Stock Exchange for 18.2 billion tenge.
Source: KASE
Home Credit Bank Bonds Added to KASE T+ List
Starting October 8, Home Credit Bank bonds (KZQ000001213, HCBNe1) will be included in the KASE T+ List.
Source: KASE
KASE Publishes Member Activity Rankings for September 2026
Kazakhstan Stock Exchange has released its exchange member activity rankings for September 2026 on its official website.
Source: KASE
KASE Index rises 0.25% to 7,862.81 points
On October 7, the KASE Index climbed by 0.25% to settle at 7,862.81 points.
Source: KASE